Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0088 | 0.9 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0083 | 0.9 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |